1.           Introduction

1.1       Report Guidance

1.2       Market Segmentation

2.           Executive Summary

2.1       Key Insights

3.           Research Methodology

3.1       Secondary Research

3.2       Primary Research

3.2.1         Hypothesis formulation:

3.2.2         Macroeconomic factor analysis:

3.2.3         Developing base number:

3.2.4         Data Triangulation:

3.2.5         Country-level data:

4.           Europe Clinical Trials Market – Key Market Dynamics

4.1       Market Drivers

4.1.1         Practice of Outsourcing Clinical Studies with Massive Rise in Number of Trials

4.1.2         Flourishing Pharmaceutical Industry with Surge in R&D Activities

4.2       Market Restraints

4.2.1         Expensive and Time-Consuming Process

4.3       Market Opportunities

4.3.1         Adoption of Decentralized Clinical Trials and Hybrid Clinical Trials

4.4       Future Trends

4.4.1         AI-Driven Clinical Trials

5.           Clinical Trials Market – Europe Analysis

5.1       Europe Clinical Trials Market Revenue (US$ Million), 2021–2031

5.2       Europe Clinical Trials Market Forecast Analysis

6.           Europe Clinical Trials Market Analysis – by Study Design

6.1       Interventional Trials

6.1.1         Overview

6.1.2         Interventional Trials: Europe Clinical Trials Market – Revenue and Forecast, 2021–2031 (US$ Million)

6.2       Expanded Access Trials

6.2.1         Overview

6.2.2         Expanded Access Trials: Europe Clinical Trials Market – Revenue and Forecast, 2021–2031 (US$ Million)

7.           Europe Clinical Trials Market Analysis – by Indications

7.1       Autoimmune/Inflammation

7.1.1         Overview

7.1.2         Autoimmune/Inflammation: Europe Clinical Trials Market – Revenue and Forecast, 2021–2031 (US$ Million)

7.2       Pain Management

7.2.1         Overview

7.2.2         Pain Management: Europe Clinical Trials Market – Revenue and Forecast, 2021–2031 (US$ Million)

7.3       Oncology

7.3.1         Overview

7.3.2         Oncology: Europe Clinical Trials Market – Revenue and Forecast, 2021–2031 (US$ Million)

7.4       Neurological Disorders

7.4.1         Overview

7.4.2         Neurological Disorders: Europe Clinical Trials Market – Revenue and Forecast, 2021–2031 (US$ Million)

7.5       Diabetes

7.5.1         Overview

7.5.2         Diabetes: Europe Clinical Trials Market – Revenue and Forecast, 2021–2031 (US$ Million)

7.6       Obesity

7.6.1         Overview

7.6.2         Obesity: Europe Clinical Trials Market – Revenue and Forecast, 2021–2031 (US$ Million)

7.7       Metabolic Disorders

7.7.1         Overview

7.7.2         Metabolic Disorders: Europe Clinical Trials Market – Revenue and Forecast, 2021–2031 (US$ Million)

7.8       Cardiovascular

7.8.1         Overview

7.8.2         Cardiovascular: Europe Clinical Trials Market – Revenue and Forecast, 2021–2031 (US$ Million)

7.9       Others

7.9.1         Overview

7.9.2         Others: Europe Clinical Trials Market – Revenue and Forecast, 2021–2031 (US$ Million)

8.           Europe Clinical Trials Market Analysis – by Phase Type

8.1       Phase I

8.1.1         Overview

8.1.2         Phase I: Europe Clinical Trials Market – Revenue and Forecast, 2021–2031 (US$ Million)

8.2       Phase II

8.2.1         Overview

8.2.2         Phase II: Europe Clinical Trials Market – Revenue and Forecast, 2021–2031 (US$ Million)

8.3       Phase III

8.3.1         Overview

8.3.2         Phase III: Europe Clinical Trials Market – Revenue and Forecast, 2021–2031 (US$ Million)

9.           Europe Clinical Trials Market – Country Analysis

9.1       Europe

9.1.1         Europe Clinical Trials Market Overview

9.1.2         Europe Clinical Trials Market – Revenue and Forecast Analysis – by Country

9.1.2.1            Europe Clinical Trials Market – Revenue and Forecast Analysis – by Country

9.1.2.2            United Kingdom: Europe Clinical Trials Market – Revenue and Forecast, 2021–2031 (US$ Million)

9.1.2.2.1           United Kingdom: Europe Clinical Trials Market Share – by Study Design

9.1.2.2.2           United Kingdom: Europe Clinical Trials Market Share – by Indications

9.1.2.2.3           United Kingdom: Europe Clinical Trials Market Share – by Phase Type

9.1.2.3            Germany: Europe Clinical Trials Market – Revenue and Forecast, 2021–2031 (US$ Million)

9.1.2.3.1           Germany: Europe Clinical Trials Market Share – by Study Design

9.1.2.3.2           Germany: Europe Clinical Trials Market Share – by Indications

9.1.2.3.3           Germany: Europe Clinical Trials Market Share – by Phase Type

9.1.2.4            France: Europe Clinical Trials Market – Revenue and Forecast, 2021–2031 (US$ Million)

9.1.2.4.1           France: Europe Clinical Trials Market Share – by Study Design

9.1.2.4.2           France: Europe Clinical Trials Market Share – by Indications

9.1.2.4.3           France: Europe Clinical Trials Market Share – by Phase Type

9.1.2.5            Spain: Europe Clinical Trials Market – Revenue and Forecast, 2021–2031 (US$ Million)

9.1.2.5.1           Spain: Europe Clinical Trials Market Share – by Study Design

9.1.2.5.2           Spain: Europe Clinical Trials Market Share – by Indications

9.1.2.5.3           Spain: Europe Clinical Trials Market Share – by Phase Type

9.1.2.6            Italy: Europe Clinical Trials Market – Revenue and Forecast, 2021–2031 (US$ Million)

9.1.2.6.1           Italy: Europe Clinical Trials Market Share – by Study Design

9.1.2.6.2           Italy: Europe Clinical Trials Market Share – by Indications

9.1.2.6.3           Italy: Europe Clinical Trials Market Share – by Phase Type

9.1.2.7            Poland: Europe Clinical Trials Market – Revenue and Forecast, 2021–2031 (US$ Million)

9.1.2.7.1           Poland: Europe Clinical Trials Market Share – by Study Design

9.1.2.7.2           Poland: Europe Clinical Trials Market Share – by Indications

9.1.2.7.3           Poland: Europe Clinical Trials Market Share – by Phase Type

9.1.2.8            Switzerland: Europe Clinical Trials Market – Revenue and Forecast, 2021–2031 (US$ Million)

9.1.2.8.1           Switzerland: Europe Clinical Trials Market Share – by Study Design

9.1.2.8.2           Switzerland: Europe Clinical Trials Market Share – by Indications

9.1.2.8.3           Switzerland: Europe Clinical Trials Market Share – by Phase Type

9.1.2.9            Sweden: Europe Clinical Trials Market – Revenue and Forecast, 2021–2031 (US$ Million)

9.1.2.9.1           Sweden: Europe Clinical Trials Market Share – by Study Design

9.1.2.9.2           Sweden: Europe Clinical Trials Market Share – by Indications

9.1.2.9.3           Sweden: Europe Clinical Trials Market Share – by Phase Type

9.1.2.10          Denmark: Europe Clinical Trials Market – Revenue and Forecast, 2021–2031 (US$ Million)

9.1.2.10.1        Denmark: Europe Clinical Trials Market Share – by Study Design

9.1.2.10.2        Denmark: Europe Clinical Trials Market Share – by Indications

9.1.2.10.3        Denmark: Europe Clinical Trials Market Share – by Phase Type

9.1.2.11          Belgium: Europe Clinical Trials Market – Revenue and Forecast, 2021–2031 (US$ Million)

9.1.2.11.1        Belgium: Europe Clinical Trials Market Share – by Study Design

9.1.2.11.2        Belgium: Europe Clinical Trials Market Share – by Indications

9.1.2.11.3        Belgium: Europe Clinical Trials Market Share – by Phase Type

9.1.2.12          Netherlands: Europe Clinical Trials Market – Revenue and Forecast, 2021–2031 (US$ Million)

9.1.2.12.1        Netherlands: Europe Clinical Trials Market Share – by Study Design

9.1.2.12.2        Netherlands: Europe Clinical Trials Market Share – by Indications

9.1.2.12.3        Netherlands: Europe Clinical Trials Market Share – by Phase Type

9.1.2.13          Rest of Europe: Europe Clinical Trials Market – Revenue and Forecast, 2021–2031 (US$ Million)

9.1.2.13.1        Rest of Europe: Europe Clinical Trials Market Share – by Study Design

9.1.2.13.2        Rest of Europe: Europe Clinical Trials Market Share – by Indications

9.1.2.13.3        Rest of Europe: Europe Clinical Trials Market Share – by Phase Type

10.        Competitive Landscape

10.1     Heat Map Analysis by Key Players

10.2     Company Positioning and Concentration

11.        Industry Landscape

11.1     Overview

11.2     Growth Strategies in Clinical Trials Market

11.3     Organic Growth Strategies

11.3.1       Overview

11.4     Inorganic Growth Strategies

11.4.1       Overview

12.        Company Profiles

12.1     QVIA Holdings Inc

12.1.1       Key Facts

12.1.2       Business Description

12.1.3       Products and Services

12.1.4       Financial Overview

12.1.5       SWOT Analysis

12.1.6       Key Developments

12.2     Parexel International Corp

12.2.1       Key Facts

12.2.2       Business Description

12.2.3       Products and Services

12.2.4       Financial Overview

12.2.5       SWOT Analysis

12.2.6       Key Developments

12.3     IXICO Plc

12.3.1       Key Facts

12.3.2       Business Description

12.3.3       Products and Services

12.3.4       Financial Overview

12.3.5       SWOT Analysis

12.3.6       Key Developments

12.4     Charles River Laboratories International Inc

12.4.1       Key Facts

12.4.2       Business Description

12.4.3       Products and Services

12.4.4       Financial Overview

12.4.5       SWOT Analysis

12.4.6       Key Developments

12.5     ICON Plc

12.5.1       Key Facts

12.5.2       Business Description

12.5.3       Products and Services

12.5.4       Financial Overview

12.5.5       SWOT Analysis

12.5.6       Key Developments

12.6     WuXi AppTec Co Ltd

12.6.1       Key Facts

12.6.2       Business Description

12.6.3       Products and Services

12.6.4       Financial Overview

12.6.5       SWOT Analysis

12.6.6       Key Developments

12.7     SGS SA

12.7.1       Key Facts

12.7.2       Business Description

12.7.3       Products and Services

12.7.4       Financial Overview

12.7.5       SWOT Analysis

12.7.6       Key Developments

12.8     Syneos Health Inc

12.8.1       Key Facts

12.8.2       Business Description

12.8.3       Products and Services

12.8.4       Financial Overview

12.8.5       SWOT Analysis

12.8.6       Key Developments

12.9     SIRO Clinpharm Pvt Ltd

12.9.1       Key Facts

12.9.2       Business Description

12.9.3       Products and Services

12.9.4       Financial Overview

12.9.5       SWOT Analysis

12.9.6       Key Developments

12.10  Thermo Fisher Scientific Inc

12.10.1    Key Facts

12.10.2    Business Description

12.10.3    Products and Services

12.10.4    Financial Overview

12.10.5    SWOT Analysis

12.10.6    Key Developments

12.11  Laboratory Corp of America Holdings

12.11.1    Key Facts

12.11.2    Business Description

12.11.3    Products and Services

12.11.4    Financial Overview

12.11.5    SWOT Analysis

12.11.6    Key Developments

12.12  CliniRx Research Private Limited

12.12.1    Key Facts

12.12.2    Business Description

12.12.3    Products and Services

12.12.4    Financial Overview

12.12.5    SWOT Analysis

12.12.6    Key Developments

12.13  Caidya

12.13.1    Key Facts

12.13.2    Business Description

12.13.3    Products and Services

12.13.4    Financial Overview

12.13.5    SWOT Analysis

12.13.6    Key Developments

12.14  Oracle Corp

12.14.1    Key Facts

12.14.2    Business Description

12.14.3    Products and Services

12.14.4    Financial Overview

12.14.5    SWOT Analysis

12.14.6    Key Developments

12.15  Medpace Holdings Inc

12.15.1    Key Facts

12.15.2    Business Description

12.15.3    Products and Services

12.15.4    Financial Overview

12.15.5    SWOT Analysis

12.15.6    Key Developments

13.        Appendix

13.1     About Us

13.2     List of Abbreviations

List of Tables

Table 1.             Europe Clinical Trials Market Segmentation

Table 2.             Europe Clinical Trials Market – Revenue and Forecast, 2021–2031 (US$ Million)

Table 3.             Europe Clinical Trials Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Study Design

Table 4.             Europe Clinical Trials Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Indications

Table 5.             Europe Clinical Trials Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Phase Type

Table 6.             Europe Clinical Trials Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Country

Table 7.             United Kingdom: Europe Clinical Trials Market – Revenue and Forecast, 2021 – 2031(US$ Million) – by Study Design

Table 8.             United Kingdom: Europe Clinical Trials Market – Revenue and Forecast, 2021 – 2031(US$ Million) – by Indications

Table 9.             United Kingdom: Europe Clinical Trials Market – Revenue and Forecast, 2021 – 2031(US$ Million) – by Phase Type

Table 10.          Germany: Europe Clinical Trials Market – Revenue and Forecast, 2021 – 2031(US$ Million) – by Study Design

Table 11.          Germany: Europe Clinical Trials Market – Revenue and Forecast, 2021 – 2031(US$ Million) – by Indications

Table 12.          Germany: Europe Clinical Trials Market – Revenue and Forecast, 2021 – 2031(US$ Million) – by Phase Type

Table 13.          France: Europe Clinical Trials Market – Revenue and Forecast, 2021 – 2031(US$ Million) – by Study Design

Table 14.          France: Europe Clinical Trials Market – Revenue and Forecast, 2021 – 2031(US$ Million) – by Indications

Table 15.          France: Europe Clinical Trials Market – Revenue and Forecast, 2021 – 2031(US$ Million) – by Phase Type

Table 16.          Spain: Europe Clinical Trials Market – Revenue and Forecast, 2021 – 2031(US$ Million) – by Study Design

Table 17.          Spain: Europe Clinical Trials Market – Revenue and Forecast, 2021 – 2031(US$ Million) – by Indications

Table 18.          Spain: Europe Clinical Trials Market – Revenue and Forecast, 2021 – 2031(US$ Million) – by Phase Type

Table 19.          Italy: Europe Clinical Trials Market – Revenue and Forecast, 2021 – 2031(US$ Million) – by Study Design

Table 20.          Italy: Europe Clinical Trials Market – Revenue and Forecast, 2021 – 2031(US$ Million) – by Indications

Table 21.          Italy: Europe Clinical Trials Market – Revenue and Forecast, 2021 – 2031(US$ Million) – by Phase Type

Table 22.          Poland: Europe Clinical Trials Market – Revenue and Forecast, 2021 – 2031(US$ Million) – by Study Design

Table 23.          Poland: Europe Clinical Trials Market – Revenue and Forecast, 2021 – 2031(US$ Million) – by Indications

Table 24.          Poland: Europe Clinical Trials Market – Revenue and Forecast, 2021 – 2031(US$ Million) – by Phase Type

Table 25.          Switzerland: Europe Clinical Trials Market – Revenue and Forecast, 2021 – 2031(US$ Million) – by Study Design

Table 26.          Switzerland: Europe Clinical Trials Market – Revenue and Forecast, 2021 – 2031(US$ Million) – by Indications

Table 27.          Switzerland: Europe Clinical Trials Market – Revenue and Forecast, 2021 – 2031(US$ Million) – by Phase Type

Table 28.          Sweden: Europe Clinical Trials Market – Revenue and Forecast, 2021 – 2031(US$ Million) – by Study Design

Table 29.          Sweden: Europe Clinical Trials Market – Revenue and Forecast, 2021 – 2031(US$ Million) – by Indications

Table 30.          Sweden: Europe Clinical Trials Market – Revenue and Forecast, 2021 – 2031(US$ Million) – by Phase Type

Table 31.          Denmark: Europe Clinical Trials Market – Revenue and Forecast, 2021 – 2031(US$ Million) – by Study Design

Table 32.          Denmark: Europe Clinical Trials Market – Revenue and Forecast, 2021 – 2031(US$ Million) – by Indications

Table 33.          Denmark: Europe Clinical Trials Market – Revenue and Forecast, 2021 – 2031(US$ Million) – by Phase Type

Table 34.          Belgium: Europe Clinical Trials Market – Revenue and Forecast, 2021 – 2031(US$ Million) – by Study Design

Table 35.          Belgium: Europe Clinical Trials Market – Revenue and Forecast, 2021 – 2031(US$ Million) – by Indications

Table 36.          Belgium: Europe Clinical Trials Market – Revenue and Forecast, 2021 – 2031(US$ Million) – by Phase Type

Table 37.          Netherlands: Europe Clinical Trials Market – Revenue and Forecast, 2021 – 2031(US$ Million) – by Study Design

Table 38.          Netherlands: Europe Clinical Trials Market – Revenue and Forecast, 2021 – 2031(US$ Million) – by Indications

Table 39.          Netherlands: Europe Clinical Trials Market – Revenue and Forecast, 2021 – 2031(US$ Million) – by Phase Type

Table 40.          Rest of Europe: Europe Clinical Trials Market – Revenue and Forecast, 2021 – 2031(US$ Million) – by Study Design

Table 41.          Rest of Europe: Europe Clinical Trials Market – Revenue and Forecast, 2021 – 2031(US$ Million) – by Indications

Table 42.          Rest of Europe: Europe Clinical Trials Market – Revenue and Forecast, 2021 – 2031(US$ Million) – by Phase Type

Table 43.          Recent Organic Growth Strategies in Clinical Trials Market

Table 44.          Recent Inorganic Growth Strategies in the Clinical Trials Market

Table 45.          List of Abbreviations

List of Figures

Figure 1.           Europe Clinical Trials Market Segmentation – Country

Figure 2.           Europe Clinical Trials Market – Key Market Dynamics

Figure 3.           Impact Analysis of Drivers and Restraints

Figure 4.           Europe Clinical Trials Market Revenue (US$ Million), 2021–2031

Figure 5.           Europe Clinical Trials Market Share (%) – by Study Design (2023 and 2031)

Figure 6.           Interventional Trials: Europe Clinical Trials Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 7.           Expanded Access Trials: Europe Clinical Trials Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 8.           Europe Clinical Trials Market Share (%) – by Indications (2023 and 2031)

Figure 9.           Autoimmune/Inflammation: Europe Clinical Trials Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 10.        Pain Management: Europe Clinical Trials Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 11.        Oncology: Europe Clinical Trials Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 12.        Neurological Disorders: Europe Clinical Trials Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 13.        Diabetes: Europe Clinical Trials Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 14.        Obesity: Europe Clinical Trials Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 15.        Metabolic Disorders: Europe Clinical Trials Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 16.        Cardiovascular: Europe Clinical Trials Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 17.        Others: Europe Clinical Trials Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 18.        Europe Clinical Trials Market Share (%) – by Phase Type (2023 and 2031)

Figure 19.        Phase I: Europe Clinical Trials Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 20.        Phase II: Europe Clinical Trials Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 21.        Phase III: Europe Clinical Trials Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 22.        Europe Clinical Trials Market Breakdown, by Key Countries, 2023 and 2031 (%)

Figure 23.        United Kingdom: Europe Clinical Trials Market – Revenue and Forecast, 2021– 2031 (US$ Million)

Figure 24.        Germany: Europe Clinical Trials Market – Revenue and Forecast, 2021– 2031 (US$ Million)

Figure 25.        France: Europe Clinical Trials Market – Revenue and Forecast, 2021– 2031 (US$ Million)

Figure 26.        Spain: Europe Clinical Trials Market – Revenue and Forecast, 2021– 2031 (US$ Million)

Figure 27.        Italy: Europe Clinical Trials Market – Revenue and Forecast, 2021– 2031 (US$ Million)

Figure 28.        Poland: Europe Clinical Trials Market – Revenue and Forecast, 2021– 2031 (US$ Million)

Figure 29.        Switzerland: Europe Clinical Trials Market – Revenue and Forecast, 2021– 2031 (US$ Million)

Figure 30.        Sweden: Europe Clinical Trials Market – Revenue and Forecast, 2021– 2031 (US$ Million)

Figure 31.        Denmark: Europe Clinical Trials Market – Revenue and Forecast, 2021– 2031 (US$ Million)

Figure 32.        Belgium: Europe Clinical Trials Market – Revenue and Forecast, 2021– 2031 (US$ Million)

Figure 33.        Netherlands: Europe Clinical Trials Market – Revenue and Forecast, 2021– 2031 (US$ Million)

Figure 34.        Rest of Europe: Europe Clinical Trials Market – Revenue and Forecast, 2021– 2031 (US$ Million)

Figure 35.        Heat Map Analysis by Key Players

Figure 36.        Company Positioning and Concentration

Figure 37.             Growth Strategies in Clinical Trials Market